Clinical trial Recruiting at 1 site Interventional Ages 1 Month to 5

Using ketamine infusion to protect the brain in children after heart surgery

Official title: Ketamine Infusion in the Postoperative Period as a Method of Cerebral Protection in Children During Surgical Correction of Congenital Heart Defects

Run by Kemerovo State Medical University · NCT06525584 · Data updated 2026-11-12

This study tests if giving a low dose of ketamine to children after heart surgery can help protect their brains from injury.

More Brain Injuries trials

Quick facts

Study typeInterventional
Ages1 Month to 5 Years
SexAll
Enrollment196 (estimated)
SponsorKemerovo State Medical University
Academic / other
Locations1 site (Kemerovo, Please Select)
StatusRecruiting
StartedNovember 5, 2023
Main results expectedDecember 30, 2028
Study endsDecember 30, 2028
Registry record updatedAugust 17, 2026
Trial IDNCT06525584 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are children aged 1 to 60 months with planned surgical interventions for atrial or ventricular septal defects.

Probably not a fit

Patients with other congenital heart diseases, significant anemia, or a history of central nervous system diseases may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the safety and effectiveness of subanesthetic doses of ketamine infusion in children undergoing surgical correction of congenital heart defects. The focus is on its potential neuroprotective effects during the postoperative period, particularly for those who have undergone operations involving cardiopulmonary bypass. Participants will receive either ketamine or a control treatment, and the outcomes will be assessed to determine the benefits of ketamine in preventing brain injuries.

Why it matters

Potential benefit: If successful, this approach could significantly reduce the risk of brain injuries in children undergoing heart surgery.

How similar studies have gone: While the use of ketamine for neuroprotection is a novel approach in this specific context, similar studies have shown promising results in other populations.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* age from 1 to 60 months
* body weight from 3.5 to 20 kg
* planned surgical intervention to correct a congenital heart defect (atrial or ventricular septal defect) with CPBё
* the presence of informed consent for participation in the study signed by the child's legal representative

Exclusion Criteria:

* lack of informed consent of the patient and parents to participate in the study,
* emergency and urgent surgical interventions;
* the presence of clinically significant anemia;
* hypo-thermic during operation, episodes of desaturation in the perioperative period;
* the presence of another congenital heart diseases besides the atrial or ventricular septal defect, as well as their combination;
* a history of central nervous system diseases;
* an installed pacemaker;
* hemodynamic instability requiring preoperative pharmacological and/or mechanical support;
* any episodes of cerebrovascular accidents in the history or periop-erative period;
* the presence of a patient with severe concomitant diseases that worsen mental and somatic conditio;
* acute infection and exacerbation of chronic infection in the perioperative period;
* concomitant autoimmune diseases;
* the presence of malignant neoplasms;
* surgical complications in the postoperative period.

Where it's running

  • Artem Ivkin
    Kemerovo, Please Select, Russia
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.